Clinical Trial Update: Citrulline and Arginase Activity in Severe Sepsis and Septic Shock

View source ↗

Summary

A completed clinical trial investigating citrulline levels and arginase activity in patients with severe sepsis and septic shock.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Snippet

Sponsor: Centre Hospitalier Universitaire de Besancon | Conditions: Intensive Care Units, Infection | Status: COMPLETED